These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33823471)

  • 101. Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset.
    Yang J; Gao Y; Duan Q; Qiu Y; Feng S; Zhan C; Huang Y; Zhang Y; Ma G; Nie K; Wang L
    Parkinsonism Relat Disord; 2022 Dec; 105():90-95. PubMed ID: 36395543
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.
    Lai CC; Wang YH; Wang CY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2018; 13():867-874. PubMed ID: 29563786
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
    Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
    Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database.
    Udovin L; Otero-Losada M; Bordet S; Chevalier G; Quarracino C; Capani F; Pérez-Lloret S
    Parkinsonism Relat Disord; 2021 May; 86():34-37. PubMed ID: 33823471
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.
    Zou Z; Yuan HB; Yang B; Xu F; Chen XY; Liu GJ; Shi XY
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009210. PubMed ID: 26816003
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease.
    Shen J; Huang YM; Song XN; Hong XZ; Wang M; Ling W; Zhang XX; Zhao HL
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27377659
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease.
    Perez-Lloret S; Otero-Losada M; Toblli JE; Capani F
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1163-1173. PubMed ID: 28836869
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
    Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
    Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy.
    Rabi DM; Khan N; Vallee M; Hladunewich MA; Tobe SW; Pilote L
    Can J Cardiol; 2008 Jun; 24(6):491-6. PubMed ID: 18548147
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension.
    Ahad A; Al-Mohizea AM; Al-Jenoobi FI; Aqil M
    Drug Deliv; 2016; 23(2):579-90. PubMed ID: 25065883
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.
    Al Khalaf MM; Thalib L; Doi SA
    Am J Cardiovasc Drugs; 2009; 9(1):29-43. PubMed ID: 19178130
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The addition of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors--what has time told us?
    Fabi MR; Teerlink JR
    Curr Heart Fail Rep; 2005 Aug; 2(2):59-64. PubMed ID: 16036052
    [TBL] [Abstract][Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.